<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-09-29 11:03:11Endocrine system Medicine Clinical medicine GnRH agonists Antianginals Hydrazines Meldonium Zwitterions Leuprorelin Insulin Doping in sport Gonadotropic cell |
Add to Reading List |
16 SeptemberProhibited List Summary of Major Modifications and Explanatory Notes SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OFCOMPETITION) PROHIBITED SUBSTANCES | Microsoft Word - DSU Degarelix FINAL sent to NICEDocID: 1oZJA - View Document |
| 16 SeptemberProhibited List Summary of Major Modifications and Explanatory Notes SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OFCOMPETITION) PROHIBITED SUBSTANCESDocID: 1nvS9 - View Document |
 | Kwartaalbericht 3e kwartaaldecember 2002 ContentsDocID: 15NH9 - View Document |
 | State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 Williston, VTwww.dvha.vermont.govDocID: 13avT - View Document |
![Public Summary Document – November 2014 PBAC Meeting 6.7 LEUPRORELIN 30 mg injection: modified release [1 x 30 mg syringe] (&)](https://www.pdfsearch.io/img/c965306afc2a6c1a1906a9417949a7bb.jpg "Public Summary Document – November 2014 PBAC Meeting 6.7 LEUPRORELIN 30 mg injection: modified release [1 x 30 mg syringe] (&)") | Public Summary Document – November 2014 PBAC Meeting 6.7 LEUPRORELIN 30 mg injection: modified release [1 x 30 mg syringe] (&)DocID: 12zdb - View Document |